1. Home
  2. SINT vs GTBP Comparison

SINT vs GTBP Comparison

Compare SINT & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SiNtx Technologies Inc.

SINT

SiNtx Technologies Inc.

HOLD

Current Price

$1.55

Market Cap

11.1M

Sector

Health Care

ML Signal

HOLD

Logo GT Biopharma Inc.

GTBP

GT Biopharma Inc.

HOLD

Current Price

$0.29

Market Cap

13.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SINT
GTBP
Founded
1996
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.1M
13.0M
IPO Year
2007
2016

Fundamental Metrics

Financial Performance
Metric
SINT
GTBP
Price
$1.55
$0.29
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
46.6K
425.6K
Earning Date
05-13-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
59.45
3.75
EPS
N/A
N/A
Revenue
$1,018,000.00
N/A
Revenue This Year
$30.26
N/A
Revenue Next Year
$413.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.40
$0.26
52 Week High
$6.78
$1.37

Technical Indicators

Market Signals
Indicator
SINT
GTBP
Relative Strength Index (RSI) 43.89 42.08
Support Level $1.51 $0.27
Resistance Level $1.90 $0.49
Average True Range (ATR) 0.11 0.02
MACD -0.00 0.00
Stochastic Oscillator 18.67 35.73

Price Performance

Historical Comparison
SINT
GTBP

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: